StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3020% below fair value
$8.35+0.09 (+1.09%)

Close on Nov 18, 2026Market cap $428.66MP/E –Yield –

Prothena Corp Public free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Prothena Corp Public

Prothena Corp Public has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Prothena Corp Public figures

See a number that looks wrong?